- Joined
- Dec 18, 2015
- Messages
- 3,216
- Reaction score
- 4,930
Realize the thread title sounds a little like the Legend of Zelda or something, but is anyone (resident, attending, whomever) using Ethos or Noona? Ethos sounds great... "Technology so advanced it will inspire you to reimagine how you’re able to treat each patient in your care." Do I need to reimagine how to treat my patients? Will there be a survival advantage? Do we do the reimagining first and studies later, or studies first and reimagining later. (Do we have good data that CBCT improved survival or lowered toxicity in XRT? I honestly off top of my head don't know, but I know it was in widespread use BEFORE any such data appeared. In rad onc, there's dosimetric/in silico, and clinical/in vivo... the two don't have to go hand in hand, and only the latter matters.) Ethos makes *a lot* of clinical decisions, on its own. Either we accept them, or not; if it turns out they should be accepted at the level of accuracy computers usually obtain, not a big role for intratreatment MD intervention? What's that mean? Re: Noona (or noona?) there's data that patient iReporting can improve survival, esp in lung ca. Although I get a little worried that we may be turning patients into scribes like we've all been turned into scribes; if a patient essentially "writes" their own weekly management note and all's we do is sign it...
Last edited: